Connect with us
//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js (adsbygoogle = window.adsbygoogle || []).push({});

Press Releases by PR Newswire

BingX Launches Pre-Market Trading for Early Access to New Digital Assets

VILNIUS, Lithuania, July 27, 2024 /PRNewswire/ — BingX, a leading cryptocurrency exch…

Warner Bros. World™ Yas Island, Abu Dhabi soars to new heights with Etihad Airways partnership

ABU DHABI, UAE, July 26, 2024 /PRNewswire/ — Warner Bros. World™ Yas Island, Abu Dhabi, th…

Pierre Fabre Laboratories receives CHMP positive opinion for BRAFTOVI® (encorafenib) in combination with MEKTOVI® (binimetinib) for the treatment of adult patients with advanced non-small cell lung cancer (NSCLC) with a BRAFV600E mutation

The positive CHMP opinion is based on results from the Phase II PHAROS trial,[1] which demo…

WiMi Built an Advanced Data Structure Architecture Using Homomorphic Encryption and Federated Learning

BEIJING, July 26, 2024 /PRNewswire/ — WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi&…

ReviR Therapeutics Raises $30 Million Series A Financing to Advance its Proprietary Oral Genetic Medicines for Multiple CNS Disorders

BRISBANE, Calif., July 26, 2024 /PRNewswire/ — ReviR Therapeutics, an AI-enabled biotechno…

Azazie Unveils Fashion Forward Atelier Collection – "Secret Garden"

LOS ANGELES, July 26, 2024 /PRNewswire/ — Azazie, the leading DTC e-tailer for all things …

MHX Jakarta 18-21 July 2024 Wrapped Up with Record Turnout, High Leads Generation and Strategic Partnerships

JAKARTA, Indonesia, July 26, 2024 /PRNewswire/ — Malaysia Healthcare Travel Council (MHTC)…

Hisense Ignites Sporting Passion with Big Screen Viewing from Paris

QINGDAO, China, July 26, 2024 /PRNewswire/ — As the world’s biggest sporting occasio…

CStone Announces European Commission Approval of Sugemalimab (Cejemly®) as First-Line Treatment for Non-Small Cell Lung Cancer

Sugemalimab becomes the world’s first anti-PD-L1 monoclonal antibody (mAb) approved in Eur…